Palliative Care

Top Story

Palliative care reduces financial burden of patients with advanced cancer, comorbidities

February 10, 2016

The immediate initiation of palliative care among hospitalized patients with incurable cancers and chronic comorbid conditions resulted in significant hospital cost savings, according to research published in Health Affairs.

“We already know that coordinated, patient-centered palliative care improves care quality, enhances survival and reduces costs for persons with cancer,” R. Sean Morrison, MD, director of the National Palliative Care Research Center and professor of geriatrics and palliative medicine at Mount Sinai’s Icahn School of Medicine, said in a press release. “Among patients with advanced cancer and other serious illnesses, aggressive treatments are often inconsistent with patients’ wishes and are associated with worse quality of life compared with other treatments. It is imperative that policymakers act to expand access to palliative care."

In the Journals

Experts reveal ‘troubling’ industry-employed strategies to delay availability of generic cancer drugs

February 8, 2016
Pharmaceutical companies have employed several strategies — including reverse payment, patent settlements and “product hopping” — to prevent…
FDA News

FDA approves EMEND to prevent nausea, vomiting after moderately emetogenic chemotherapy

February 4, 2016
The FDA approved use of single-dose fosaprepitant dimeglumine in combination with other antiemetic medicines for the prevention of delayed nausea and vomiting in…

Memorial Sloan Kettering Cancer Center announces appointments

January 27, 2016
Memorial Sloan Kettering Cancer Center announced the following awards and appointments:Kantoff is a medical oncologist and clinical researcher who specializes in…
CME

The Patient with Severe Leukocytosis

No commercial support for this activity.

Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML)…
More »
Featured
CME

The Patient with Lymphadenopathy

No commercial support for this activity.

Castleman’s disease is a rare lymphoproliferative disorder that is characterized by enlargement of 1 (unicentric) or…
More »
In the Journals

Palliative care reduces financial burden of patients with advanced cancer, comorbidities

February 10, 2016
The immediate initiation of palliative care among hospitalized patients with incurable cancers and chronic comorbid conditions resulted in…
In the Journals

Experts reveal ‘troubling’ industry-employed strategies to delay availability of generic cancer drugs

February 8, 2016
Pharmaceutical companies have employed several strategies — including reverse payment, patent settlements and “product hopping”…
FDA News

FDA approves EMEND to prevent nausea, vomiting after moderately emetogenic chemotherapy

February 4, 2016
The FDA approved use of single-dose fosaprepitant dimeglumine in combination with other antiemetic medicines for the prevention of delayed nausea and…

Memorial Sloan Kettering Cancer Center announces appointments

January 27, 2016
Memorial Sloan Kettering Cancer Center announced the following awards and appointments:Kantoff is a medical oncologist and clinical researcher who…
In the JournalsPerspective

Hospital expenditures among dying patients with cancer highest in US, Canada, Norway

January 19, 2016
Hospital expenditures near the end of life among older patients with cancer appeared higher in the U.S., Canada and Norway than other Western…
In the Journals

Earlier hospice, avoidance of ICU improve family members’ perceptions of end-of-life care

January 19, 2016
Factors including early hospice enrollment, avoidance of ICU admission within 30 days of death and death occurring outside the hospital appeared…
CME

The Patient with Severe Leukocytosis

January 15, 2016 Expires: 1/15/2017
Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML). Although imatinib has been the…
In the JournalsPerspective

Initiation of palliative care in ED improves quality of life

January 14, 2016
Palliative care initiated in the emergency department appeared to improve quality of life without shortening survival among patients with advanced…

ASCO elects four members to board of directors

January 7, 2016
Four oncology leaders have been elected to ASCO’s board of directors.The new members of the board of directors will begin 4-year terms in June.
Meeting News Coverage

Top Takeaways from ASH: Palliative care emerges in treatment for hematologic malignancies

December 28, 2015
An educational session presented over two mornings at the ASH Annual Meeting and Exposition provided a comprehensive view of implementing palliative…
More Headlines »
morganatic-roan
morganatic-roan